This chapter presents conclusions about developing a unique RP-HPLC method for analyzing clopidogrel in bulk and pharmaceutical dosage forms. The method is simple, accurate, sensitive, repeatable, and cost-effective for quantifying clopidogrel between 48-150 μg/mL. It is linear, with a correlation of 0.998. Recovery is nearly 100% and repeatability has an RSD of less than 1%, improving on older techniques. The procedure can be used to regularly quality check clopidogrel API or pharmaceuticals.
Development and Validation of A RP-HPLC Method For Simultaneous Quantification of Pilocarpine Hydrochloride and Timolol Maleate in Ophthalmic Formulations
Stability Indicating RP-HPLC Method For The Determination of Terbutaline Sulphate, Guaifenesin, Ambroxol Hydrochloride and Preservatives Content in Liquid Formulations
This chapter presents conclusions about developing a unique RP-HPLC method for analyzing clopidogrel in bulk and pharmaceutical dosage forms. The method is simple, accurate, sensitive, repeatable, and cost-effective for quantifying clopidogrel between 48-150 μg/mL. It is linear, with a correlation of 0.998. Recovery is nearly 100% and repeatability has an RSD of less than 1%, improving on older techniques. The procedure can be used to regularly quality check clopidogrel API or pharmaceuticals.
This chapter presents conclusions about developing a unique RP-HPLC method for analyzing clopidogrel in bulk and pharmaceutical dosage forms. The method is simple, accurate, sensitive, repeatable, and cost-effective for quantifying clopidogrel between 48-150 μg/mL. It is linear, with a correlation of 0.998. Recovery is nearly 100% and repeatability has an RSD of less than 1%, improving on older techniques. The procedure can be used to regularly quality check clopidogrel API or pharmaceuticals.
This chapter presents conclusions about developing a unique RP-HPLC method for analyzing clopidogrel in bulk and pharmaceutical dosage forms. The method is simple, accurate, sensitive, repeatable, and cost-effective for quantifying clopidogrel between 48-150 μg/mL. It is linear, with a correlation of 0.998. Recovery is nearly 100% and repeatability has an RSD of less than 1%, improving on older techniques. The procedure can be used to regularly quality check clopidogrel API or pharmaceuticals.
Conclusion : The creation of a unique RP-HPLC technology for the analysis of
clopidogrel in both bulk and pharmaceutical dosage forms is presented in this paper. This method is simple, trustworthy, linear, accurate, sensitive, repeatable, and economically advantageous for the quantitative measurement of clopidogrel in bulk and in tablet formulations. The technique worked effectively across all of the criteria looked at, and none of the other active ingredients or additives in the formulations interfered. The approach had a linear relationship with concentration from 48 to 150 µg/mL (r = 0.998). The recovery is nearly 100%. The RSD was less than 1%, which is a significant improvement over older techniques.. The procedure may be used for regular quality checking of API or pharmaceutical clopidogrel.
Shree Dev Bhoomi Institute of Education Science and Technology, Dehradun Page 51
Development and Validation of A RP-HPLC Method For Simultaneous Quantification of Pilocarpine Hydrochloride and Timolol Maleate in Ophthalmic Formulations
Stability Indicating RP-HPLC Method For The Determination of Terbutaline Sulphate, Guaifenesin, Ambroxol Hydrochloride and Preservatives Content in Liquid Formulations